Career history of M. Nixon Ellis
Former positions of M. Nixon Ellis
| Companies | Position | Start | End |
|---|---|---|---|
Argolyn Bioscience, Inc.
 Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | President | 2009-05-25 | 2009-11-25 |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Chief Operating Officer | 1994-12-31 | - |
| President | 1994-12-31 | - | |
| Burroughs Wellcome | Corporate Officer/Principal | - | - |
| Wellcome Foundation Ltd | Corporate Officer/Principal | - | - |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Chief Tech/Sci/R&D Officer | - | - |
| PHASEBIO PHARMACEUTICALS, INC. | President | - | - |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | President | - | - |
Training of M. Nixon Ellis
| University of Georgia | Doctorate Degree |
| The University of North Carolina at Charlotte | Masters Business Admin |
| University of South Carolina | Undergraduate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 3 |
Operational
| President | 4 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Health Technology |
| Wellcome Foundation Ltd | Commercial Services |
| Burroughs Wellcome |
- Stock Market
- Insiders
- M. Nixon Ellis
- Experience
